G G Dandekar (505250)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹110.51 |
| Market Cap | ₹52.62 Cr |
| P/E Ratio | 0 |
| ROCE | -2.03% |
| ROE | 4.96% |
| Dividend Yield | 0% |
| Profit Growth | -105.76% |
| Debt/Equity | — |
| Sales Growth | -11.96% |
| 52-Week Range | ₹46.5 — ₹110.51 |
| Sector | Industrial Manufacturing |
| Book Value | ₹91.93 |
Strengths
- Book value of ₹91.93 per share provides a tangible asset baseline; P/B of 1.20 is not an excessive premium.
- Trailing ROE of 4.96% shows the equity was at least marginally earnings-positive historically.
- Small market cap of ₹53 crore means even modest operational improvements could have a visible impact on per-share value.
Concerns
- Latest quarter net loss of ₹3 crore on sales of just ₹1 crore implies severe cash burn and no core operating profitability.
- Piotroski F-Score of 2/9 indicates very weak financial health and a high risk of continued deterioration.
- Sales growth of -11.96% and profit growth of -105.76% show a contracting business with no earnings support.
- Insufficient data—promoter holding, debt/equity, and P/E at 0.00—means the margin of safety cannot be validated.
AI Analysis
This is not a business I can put into the 'wonderful company' pile. At ₹110.51, G G Dandekar carries a market capitalisation of just ₹53 crore, and it trades at 1.20 times book value, with book at ₹91.93. That seems reasonable until you ask what the book capital earns. The answer is not much: ROCE is -2.03%, and the latest quarter lost ₹3 crore on sales of only ₹1 crore. Profit growth is down 105.76%, sales have fallen about 12%, and the Piotroski score is 2 out of 9. These are the fingerprints of a business destroying value, not creating it. The P/E is meaningless because earnings have disappeared. There is no dividend to compensate for the wait. I cannot even check promoter holding or debt/equity, so the balance-sheet safety is unknown. I never buy stocks; I buy businesses, and this business, as it stands, has no demonstrated earning power. The stock is at its 52-week high, but a rising price is not a margin of safety. For a Graham investor, this could be an asset-led situation only if it were selling well below book; at 1.2 times book, there is limited cushion. I need evidence of a genuine turnaround: flat-to-rising sales, a positive ROCE, a better F-score, and disclosed financials. Until then, the rational course is to wait. The odds do not favour the minority shareholder.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer